- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hereditary Breast and Ovarian Cancer in New Zealand
Total 7727 results
-
Yale UniversityCompletedBreast Cancer | Early Stage Estrogen Receptor (ER) Positive Breast CancerUnited States
-
Max SungTerminatedBreast Cancer | Metastatic CancerUnited States
-
Memorial Sloan Kettering Cancer CenterUnited States Department of Defense; Genentech, Inc.CompletedBreast Cancer Metastases | HER2 Positive BreastUnited States
-
University Health Network, TorontoActive, not recruitingOvarian Cancer | Fallopian Tube Cancer | Neoadjuvant Treatment | Debulking Surgical ProceduresCanada, United Kingdom, Spain, New Zealand
-
SanofiCompletedCancer | Breast CancerUnited States, France
-
National Cancer Institute (NCI)CompletedBreast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
EpiAxis TherapeuticsThe Canberra Hospital; Southern Medical Day Care Centre; Liverpool Cancer Therapy...CompletedMetastatic Breast CancerAustralia
-
Massachusetts General HospitalAstraZeneca; OncoPep, Inc.Active, not recruitingBreast CancerUnited States
-
Dartmouth-Hitchcock Medical CenterCompletedPalpable Breast CancerUnited States
-
New Mexico Cancer Care AllianceGenentech, Inc.; NYU Langone HealthCompletedOvarian CancerUnited States
-
NYU Langone HealthGenentech, Inc.; University of New Mexico Cancer CenterCompleted
-
CytomX TherapeuticsTerminatedBreast Cancer | Head and Neck Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Solid Tumor, AdultUnited States, Spain, Netherlands, United Kingdom
-
Nancy Chan, MDMerck Sharp & Dohme LLCActive, not recruiting
-
GlaxoSmithKlineTerminatedNeoplasms, Breast | Relapsed Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingHormone Receptor Positive Metastatic Breast CancerUnited States
-
Dana-Farber Cancer InstituteCompletedEarly Stage Breast CancerUnited States
-
Canadian Cancer Trials GroupHoffmann-La RocheActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterStryker Instruments; pHLIP Inc.RecruitingBreast CancerUnited States
-
Rutgers, The State University of New JerseyUnknownBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Metastatic Cancer | Melanoma (Skin) | Liver CancerUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); Cianna Medical, Inc.TerminatedStage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIC Breast Cancer | Lobular Breast Carcinoma In Situ | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Ductal Breast Carcinoma In Situ | Mucinous Breast Carcinoma | Tubular Breast Carcinoma and other conditionsUnited States
-
Rexahn Pharmaceuticals, Inc.TerminatedSolid Tumor | Triple Negative Breast CancerUnited States
-
Rutgers, The State University of New JerseyTerminatedBreast Cancer | Resistance TrainingUnited States
-
Georgetown UniversityTerminatedBreast Cancer | Neoplasms, Breast | Cancer of the BreastUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)CompletedBreast Cancer | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Melanoma (Skin)United States
-
Xencor, Inc.RecruitingColorectal Cancer | Castration-resistant Prostate Cancer | Head and Neck Squamous Cell Carcinoma | Urothelial Carcinoma | Ovarian Cancer, Epithelial | TNBC - Triple-Negative Breast Cancer | Renal Cell Carcinoma, Clear Cell | Melanoma Excluding Uveal Melanoma | Non-small Cell Lung Cancer, Squamous or...United States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingGynecologic Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage III Breast Cancer | Stage III Gynecologic Cancer | Stage III Colorectal Cancer | Stage I Colorectal Cancer | Stage II Colorectal Cancer | Stage I Gynecologic... and other conditionsUnited States
-
Eli Lilly and CompanyCompletedMetastatic Breast CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruiting
-
Rutgers, The State University of New JerseyRutgers Cancer Institute of New Jersey; Elekta Limited; Cianna Medical, Inc.CompletedInvasive Breast Carcinoma | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Estrogen Receptor Positive | Progesterone Receptor Positive | Ductal Breast Carcinoma In SituUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Male Breast Carcinoma | Stage IV Breast Cancer AJCC...United States
-
CairnSurgical, Inc.SuspendedBreast Cancer FemaleUnited States, Canada, United Kingdom
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedStage 0 Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Lobular Breast Carcinoma In Situ | Ductal Breast Carcinoma In Situ | BRCA1 Mutation Carrier | BRCA2 Mutation CarrierUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.RecruitingBreast Cancer | HER2-positive Breast Cancer | Hormone Receptor Positive Breast Cancer | Invasive Carcinoma of the Breast | Node Negative Breast Cancer | Micrometastasis Breast CancerUnited States
-
Marker Therapeutics, Inc.CompletedBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterMemorial University Medical CenterActive, not recruiting
-
Dana-Farber Cancer InstituteNanoString Technologies, Inc.Active, not recruiting
-
Infinity Pharmaceuticals, Inc.TerminatedBreast Cancer | Metastatic Breast Cancer | HER2 Positive Breast Cancer | Cancer of the BreastUnited States, Spain
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseRecruitingTriple Negative Breast Cancer | HER2-positive Breast Cancer | Leptomeningeal DiseaseUnited States
-
Far Eastern Memorial HospitalCompletedIntraperitoneal Chemotherapy, Bevacizumab, Ovarian CancerTaiwan
-
Dana-Farber Cancer InstituteCompletedBreast Cancer | Colorectal CancerUnited States
-
QuantumLeap Healthcare CollaborativeRecruitingBreast Cancer | Breast Neoplasms | Breast Tumors | HER2-positive Breast Cancer | Angiosarcoma | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingStage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IIIC Breast Cancer | HER2/Neu Negative | Stage III Breast Cancer | Postmenopausal | Estrogen Receptor StatusUnited States
-
National Cancer Institute (NCI)CompletedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | HER2/Neu PositiveUnited States, Puerto Rico
-
National Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Invasive Breast Carcinoma | Breast AdenocarcinomaUnited States
-
Polyphor Ltd.CompletedMetastatic Breast CancerSpain, United States
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingOvarian Endometrioid Adenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Stage III Fallopian Tube Cancer AJCC v7 | Stage III Primary Peritoneal Cancer... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterVerastem, Inc.RecruitingLow-Grade Serous Ovarian CancerUnited States
-
Eisai Inc.Completed
-
Gary MorrowNational Cancer Institute (NCI); Stanford UniversityCompletedSleep Disorder | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)Not yet recruitingCancer, Breast | Health Care UtilizationUnited States